Somatic mutations predict outcomes of hypomethylating therapy in patients with myelodysplastic syndrome.

Jung, Seung-Hyun

Somatic mutations predict outcomes of hypomethylating therapy in patients with myelodysplastic syndrome. [electronic resource] - Oncotarget Aug 2016 - 55264-55275 p. digital

Publication Type: Journal Article

1949-2553

10.18632/oncotarget.10526 doi


Adult
Aged
Azacitidine--therapeutic use
DNA (Cytosine-5-)-Methyltransferases--genetics
DNA Methylation--drug effects
DNA Methyltransferase 3A
DNA-Binding Proteins--genetics
Dioxygenases
Female
Genes, p53
Genes, ras
Humans
Male
Middle Aged
Mutation
Myelodysplastic Syndromes--drug therapy
Prognosis
Proto-Oncogene Proteins--genetics
Splicing Factor U2AF--genetics